Clinical Advisor is categorized under Periodical Publishers in New York City, NY .
Clinical Advisor was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.
If you are seeking more information, feel free to contact Lee Maniscalco, Chief Executive Officer at the company’s single location by writing to 114 West 26th St, New York City, New York NY 10001 or by phoning (646) 638-6000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Advisor |
| Contact Person: | Lee Maniscalco, Chief Executive Officer |
| Address: | 114 West 26th St, New York City, New York 10001 |
| Phone Number: | (646) 638-6000 |
| Website Address: | clinicaladvisor.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Periodical Publishers |
| SIC Code: | 2721 |
| NAICS Code: | 5111200 |
| Share This Business: |
Clinical Advisor was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Lee Maniscalco, Chief Executive Officer for inquiries that concern Clinical Advisor by calling the company number (646) 638-6000, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Advisor can be found at the coordinates 40.744954,-73.991919 as well as the street address 114 West 26th St in New York City, New York 10001.
For its online presence, you may visit Clinical Advisor’s website at clinicaladvisor.com and engage with its social media outlets through on Twitter and on Facebook.